生体内ゲノム編集技術を利用した次世代バイオ薬治療法の開発

• Project/Area Number: 25K21779
• Research Category: Grant-in-Aid for Challenging Research (Pioneering)
• Allocation Type: Multi-year Fund
• Review Section: Medium-sized Section 53:Organ-based internal medicine and related fields
• Research Institution: The University of Osaka
• Principal Investigator: 鈴木 啓一郎 大阪大学, 大学院基礎工学研究科, 教授 (70433654)
• Project Period (FY): 2025-06-27 – 2029-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥25,610,000 (Direct Cost: ¥19,700,000、Indirect Cost: ¥5,910,000); Fiscal Year 2028: ¥7,020,000 (Direct Cost: ¥5,400,000、Indirect Cost: ¥1,620,000); Fiscal Year 2027: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000); Fiscal Year 2026: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000); Fiscal Year 2025: ¥6,630,000 (Direct Cost: ¥5,100,000、Indirect Cost: ¥1,530,000)